Top 53 Wuhan Startups to Watch in 2026
Wuhan's startup scene is marked by a focus on advanced manufacturing and biotechnology. The city is home to new companies in fields ranging from semiconductors to electric vehicles.
Electric vehicle maker Voyah has raised CN¥5B in funding. Another company, smart technology platform Xingji Meizu, was founded in 2023 and has already secured CN¥2B.
Below is our list of 53 Wuhan startups worth keeping an eye on.
Failory's Top 10 Picks
Voyah builds a line of premium electric vehicles that incorporate autonomous driving technology. The automaker is focused on international expansion, introducing its luxury EVs to new global markets.
| Year Founded | 2019 |
| Founders | — |
| Funding Amount | CN¥5B |
| Startup Size | Lean Team (11-50) |
| Last Funding Status | Series A |
| Top Investors | Bank of China, Ganfeng Lithium, Industrial and Commercial Bank of China, Sunwoda Electronic, BOCOM International |
iRegene develops RNA interference (RNAi) therapies to treat complex neurodegenerative and rare diseases. The company's proprietary AI platform helps accelerate the discovery and development of these novel treatments.
| Year Founded | 2017 |
| Founders | Jun Wei |
| Funding Amount | CN¥200M |
| Startup Size | Mid-Size Team (51-250) |
| Last Funding Status | Series B |
| Top Investors | Northern Light Venture Capital, Lotus Lake Ventures, Wuhan Optics Valley Industrial Investment, Chengdu High-tech Ceyuan Capital, Chuangjing Capital |
Xingji Meizu Group creates a technology ecosystem that connects smartphones, vehicles, and AR smart glasses. They focus on deep software and hardware integration to deliver a seamless experience as users move between their personal devices and their car.
| Year Founded | 2023 |
| Founders | — |
| Funding Amount | CN¥2B |
| Startup Size | — |
| Last Funding Status | Series A |
| Top Investors | Winreal Investment, Harvest Global Investments, Xingyuan Fund, Asia Investment Fund, QC Capital |
Polarisic creates high-performance chips focused on depth perception and low-light imaging. Their technology provides advanced visual sensing capabilities for electronics used in challenging lighting conditions.
| Year Founded | 2021 |
| Founders | — |
| Funding Amount | CN¥250M |
| Startup Size | Mid-Size Team (51-250) |
| Last Funding Status | Series A |
| Top Investors | Legend Capital, Boyu Capital, CMB International Capital Corporation, SigmaStar, Nanshan War Xintou |
ABclonal provides the global life sciences community with a growing catalog of high-quality antibodies and molecular enzyme reagents. Their tools are designed to accelerate scientific research and the development of new diagnostics.
| Year Founded | 2011 |
| Founders | — |
| Funding Amount | $282.1M |
| Startup Size | Large Team (251-1,000) |
| Last Funding Status | Series D |
| Top Investors | HSG, LYFE Capital, Loyal Valley Capital, Oriza Fund of Funds, CMB International Capital Corporation |
Chime Biologics provides contract development and manufacturing (CDMO) services for the global biopharmaceutical sector. Their team offers end-to-end support, helping clients navigate the entire lifecycle from early drug development to large-scale commercial production.
| Year Founded | 2013 |
| Founders | Andrew Ng, John Zeng |
| Funding Amount | $332.4M |
| Startup Size | Large Team (251-1,000) |
| Last Funding Status | Series A |
| Top Investors | BioVenture, Panacea Venture, Fidelity International, VMS Asset Management, Panacea Venture |
Cobot builds an intelligent operating system designed to control and manage industrial robots. Their platform combines deep learning and 3D vision to help robots perform complex manipulation tasks in sectors like automotive and logistics.
| Year Founded | 2016 |
| Founders | Miao Li, Yan Li |
| Funding Amount | CN¥252M |
| Startup Size | Mid-Size Team (51-250) |
| Last Funding Status | Series C |
| Top Investors | Matrix Partners China, GGV Capital, AlphaX Partners, Guoxin Fund, Empower Investment |
XW Laboratories discovers and develops potential new medicines for treating neurological disorders. The company's pipeline is built entirely from its own internal research, creating a portfolio of proprietary drug candidates.
| Year Founded | 2014 |
| Founders | Jia-Ning Xiang |
| Funding Amount | $57.5M |
| Startup Size | Lean Team (11-50) |
| Last Funding Status | Series C |
| Top Investors | Kleiner Perkins, WI Harper Group, Panacea Venture, WuXi Healthcare Ventures, CDIB Capital |
Nekcom develops immersive video games for PC, console, and virtual reality platforms. The studio is behind titles like the post-apocalyptic action RPG Showa American Story and the horror puzzle game DYING: Reborn.
| Year Founded | 2011 |
| Founders | Xiangyu Luo |
| Funding Amount | $23M |
| Startup Size | Lean Team (11-50) |
| Last Funding Status | Corporate Round |
| Top Investors | Galaxy Interactive, GCL Global Holdings |
Yangtze Memory Technologies develops and manufactures 3D NAND flash memory chips used in a wide range of data storage applications. Their work establishes them as a key producer of semiconductor memory solutions for both consumer electronics and enterprise systems.
| Year Founded | 2016 |
| Founders | Simon Yang |
| Funding Amount | CN¥50.6B |
| Startup Size | Enterprise Organization (5,001+) |
| Last Funding Status | Undisclosed |
| Top Investors | China Integrated Circuit Industry Investment Fund (CICF), Changjiang Industrial Investment Group, Wuhu Wenming Quanhong Investment Management, Hubei Changsheng Development |
43 Additional Wuhan Startups Worth Following
Our top picks offer just a glimpse into the city's growing startup community. Many more companies are making big moves, especially in fields like biotech, healthcare, and advanced manufacturing.
From brand new ventures to established companies, these startups have collectively raised billions to fund their growth. Here is a look at the other companies shaping Wuhan's startup scene.
| Startup | Industry | Year Founded | Amount Raised | Last Funding Round |
|---|---|---|---|---|
Yaobangmang | Healthcare | 2015 | CN¥183M | Series C |
XMC | Manufacturing | 2006 | CN¥2.7B | Undisclosed |
Neurophth Therapeutics | Biotech | 2016 | $237.4M | Series C |
Ankon Medical Technologies | Healthcare | 2009 | $100M | Venture Round |
Edgene Biot | Biotech | 2019 | $1.4M | Seed |
Minsheng New Technology | Hardware | 2019 | CN¥800M | Venture Round |
Silicon Integrated | Hardware | 2016 | CN¥180M | Series D |
FuBay Technology | Fintech | 2024 | CN¥60M | Seed |
Handing Intelligent | Mobility | 2020 | $14.1M | Series B |
In-Driving | AI | 2015 | $30.5M | Venture Round |
ExPace | Mobility | 2016 | CN¥2.8B | Series B |
Langlai Technology | Biotech | 2013 | CN¥500M | Series A |
Binhui Biotech | Biotech | 2010 | CN¥1B | Series C |
Xinchuangyuan Semiconductor | Hardware | 2021 | CN¥480M | Series A |
KM Soft | Data | 2001 | CN¥200M | Venture Round |
Landing Medical High Technology | AI | 2000 | CN¥320M | Series D |
YZY Bio | Biotech | 2010 | CN¥450M | Series C |
Wuhan Huazhong Numerical Control Co., Ltd. | Manufacturing | 1994 | CN¥856.8M | Private Equity |
JIMU Intelligent | AI | 2011 | $46.3M | Series C |
CMLabs | Healthcare | 2013 | $80.9M | Series C |
Wayz.ai | AI | 2017 | $80M | Venture Round |
NIO Power | Other | — | CN¥1.5B | Venture Round |
Jiahe | Data | 2013 | $28.5M | Series B |
Zdeer | AI | 2014 | $15.2M | Series B |
Hipot | Logistics | 2021 | CN¥450M | Series A |
Yusheng Optoelectronics | Hardware | 2001 | CN¥90M | Venture Round |
Greenon Biotech | AgTech | 2019 | CN¥100M | Seed |
Cadvis Biotechnology | Biotech | 2018 | CN¥200M | Series B |
Xingdian Catering | Food | 2020 | CN¥150M | Series A |
Hzymes Biotechnology | Manufacturing | 2015 | CN¥800M | Series C |
Aroptics Tech | Enterprise | 2015 | CN¥200M | Series C |
Dameng Database | Infrastructure | 2000 | CN¥100M | Series A |
MLog Tianqijia | Data | 2014 | $38.2M | Series D |
Bai Sijie | Hardware | 2012 | CN¥100M | Series A |
Banma Kuaipao | Mobility | 2015 | $181.5M | Series D |
Immorta | Mobility | 2022 | CN¥200M | Series A |
HGC Lighting Solution | Hardware | 2011 | CN¥215M | Series C |
Mai Yi | Healthcare | 2013 | CN¥280M | Venture Round |
Shixianghui | Media | 2018 | $44.6M | Series B |
MetWare | Healthcare | 2015 | CN¥100M | Series B |
EasyLinkin | Enterprise | 2013 | $87.3M | Series C |
Xiaoming Taiji | Media | 2016 | CN¥150M | Venture Round |
Zhiyin Manke | Media | 2008 | CN¥567M | Private Equity |

